Analytical Data
-
Gene name
Y1BFP
- Application
-
Alternative Names
BFP; Y1-blue fluorescent protein
-
Species
Others
-
Source
E. coli
-
Tag
His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
BAG71497
-
Expression Region
M1-W200
-
Protein Length
Full Length
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Y1BFP is a recombinant protein that has garnered significant attention in the field of molecular biology and biotechnology due to its potential applications in various research and therapeutic areas. It is derived from the Yersinia pestis bacterium, which is responsible for the plague, and has been investigated for its unique properties that may aid in the understanding of pathogenic mechanisms and immune responses. The study of Y1BFP focuses on its role in host-pathogen interactions, offering insights into how bacterial proteins can evade immune detection and promote infection. Furthermore, the modification and expression of Y1BFP in various host systems, such as E. coli and yeast, have enabled researchers to explore its structural characteristics and functional capabilities. This research is critical not only for developing novel antibacterial strategies but also for designing vaccines and diagnostic tools against infectious diseases. By elucidating the biological functions and mechanisms of Y1BFP, scientists aim to contribute to the broader understanding of disease processes and enhance the efficacy of therapeutic interventions. This protein’s potential as a biomarker for infections caused by Yersinia and its applications in synthetic biology further highlight its significance in contemporary biomedical research.
